This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Vifor Pharma Dividende
Zukünftiges Wachstum Kriterienprüfungen 3/6
Wichtige Informationen
1.1%
Dividendenausschüttung
88%
Ausschüttungsquote
| Durchschnittlicher Branchenertrag | 2.2% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Gewinn pro Aktie | US$2.26 |
| Prognose der Dividendenrendite | 1.1% |
Aktuelle Dividendenentwicklung
Recent updates
Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: GNHA.F's dividends per share have been stable in the past 10 years.
Wachsende Dividende: GNHA.F's dividend payments have increased over the past 10 years.
Dividendenrendite im Vergleich zum Markt
| Vifor Pharma Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (GNHA.F) | 1.1% |
| Untere 25 % des Marktes (US) | 1.4% |
| Markt Top 25 % (US) | 4.3% |
| Branchendurchschnitt (Pharmaceuticals) | 2.2% |
| Analystenprognose (GNHA.F) (bis zu 3 Jahre) | 1.1% |
Bemerkenswerte Dividende: GNHA.F's dividend (1.11%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.6%).
Hohe Dividende: GNHA.F's dividend (1.11%) is low compared to the top 25% of dividend payers in the US market (4.56%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: At its current payout ratio (88.5%), GNHA.F's payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Insufficient data to calculate cash payout ratio to determine if its dividend payments are covered by cash flows.